Joseph A. M. Truluck
2023
In 2023, Joseph A. M. Truluck earned a total compensation of $389K as Chief Financial Officer at ADIAL PHARMACEUTICALS, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Option Awards | $30,547 |
| Salary | $276,250 |
| Other | $12,236 |
| Total | $389,033 |
Truluck received $276.3K in salary, accounting for 71% of the total pay in 2023.
Truluck also received $70K in bonus, $30.5K in option awards and $12.2K in other compensation.
Rankings
In 2023, Joseph A. M. Truluck's compensation ranked 2,197th out of 2,790 executives tracked by ExecPay. In other words, Truluck earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,197 out of 2,790 | 21st |
Division Manufacturing | 1,233 out of 1,530 | 19th |
Major group Chemicals And Allied Products | 741 out of 869 | 15th |
Industry group Drugs | 722 out of 832 | 13th |
Industry Pharmaceutical Preparations | 515 out of 597 | 14th |
Source: SEC filing on September 27, 2024.
Truluck's colleagues
We found two more compensation records of executives who worked with Joseph A. M. Truluck at ADIAL PHARMACEUTICALS in 2023.
News
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2023 pay falls 21% to $802K
September 27, 2024
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2022 pay jumps 118% to $1M
September 29, 2023
ADIAL PHARMACEUTICALS CEO William Stilley's 2021 pay rises 8% to $1.2M
September 1, 2022
ADIAL PHARMACEUTICALS CEO William Stilley's 2019 pay jumps 95% to $2.4M
July 20, 2020
ADIAL PHARMACEUTICALS CEO William Stilley's 2018 pay jumps 232% to $1.2M
July 8, 2019